Joel Isaacson & Co., LLC
Q1 2014 13F-HR/A Holdings
Net value change ($000)
+22,570
(8.2%)
New positions
101
Sold out positions
21
Turnover %
3.6%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| SDY | 6,891 | 7.9% |
| Novartis AG | 1,383 | NEW |
| Nestle SA | 1,372 | NEW |
| VO | 1,278 | 21.7% |
| VIG | 1,265 | 4.4% |
| SPY | 947 | 18.2% |
| ROCHE HOLDING | 896 | NEW |
| VYM | 885 | 5.5% |
| ETO | 735 | 332.6% |
| Fresenius Medical Care AG & Co KGaA | 661 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| Vitamin Shoppe, Inc. | -676 | -100.0% |
| DWX | -502 | -30.1% |
| CELG | -467 | -20.4% |
| VOD | -315 | -100.0% |
| GAM | -251 | -100.0% |
| SHEL | -209 | -52.4% |
| XOM | -176 | -3.9% |
| BANC | -173 | -100.0% |
| Old COPPER Company, Inc. | -143 | -62.4% |
| BEAM INC | -133 | -50.8% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|